| Description |
1 online resource (viii, 335 pages) : illustrations (some color) |
| Contents |
Introduction; Contents; Part I: Epidemiology: Infections in Patients with Hematologic Malignancies; 1: Infections in Patients with Acute Leukemia; 1.1 Introduction; 1.2 Nature of Febrile Episodes; 1.3 Clinically Documented Infections; 1.4 Microbiologically Documented Infections; 1.5 Sites of Infection; 1.6 Spectrum of Bacterial Infection; 1.6.1 Gram-Positive Organisms; 1.6.2 Gram-Negative Bacilli; 1.7 Fungal Infections; 1.7.1 Viral Infections; 1.8 Summary; References; 2: Infections in Patients with Malignant Lymphomas; 2.1 Introduction; 2.2 Neutropenia; 2.3 Humoral Immunity |
|
2.4 Cell-Mediated Immunity2.5 Bacterial Infections; 2.6 Mycobacterial Infections; 2.7 Fungal Infections; 2.8 Parasitic Infections; 2.9 Central Nervous System Infections; 2.10 Pulmonary Infections; References; 3: Consequences from Specific Treatment Modalities; 3.1 Purine Analogs; 3.2 Monoclonal Antibodies; 3.2.1 Anti-CD20 Antibodies; 3.2.2 Alemtuzumab (Anti-CD52 Antibody); 3.2.3 Antibodies to Tumor Necrosis Factor Alpha (TNF-Alpha); References; 4: Infections After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation; 4.1 Introduction |
|
4.2 Risk for and Epidemiology of Infection4.2.1 Pre-Engraftment Period; 4.2.2 Post-engraftment Period; 4.3 Summary; References; 5: Microbiological Background; 5.1 Introduction; 5.2 Bacterial Infections; 5.2.1 Gram-Positive Bacteria and Their Antimicrobial Susceptibility; 5.2.1.1 Coagulase-Negative Staphylococci (CNS); 5.2.1.2 Staphylococcus aureus; 5.2.1.3 Enterococci; 5.2.1.4 Viridans Streptococci; 5.2.1.5 Streptococcus pneumoniae; 5.2.2 Gram-Negative Bacteria and Their Antimicrobial Susceptibility; 5.2.2.1 Enteric Gram-Negatives; 5.2.2.2 Pseudomonas aeruginosa |
|
5.2.2.3 Other Non-fermentative Bacteria5.2.3 Anaerobic Bacteria; 5.2.4 Unusual Bacteria; 5.3 Invasive Fungal Infections; 5.3.1 Candida spp.; 5.3.2 Other Opportunistic Yeast-Like Fungi; 5.3.3 Aspergillus spp.; 5.3.4 Zygomycetes; 5.3.5 Other Rare Molds; References; Part II: Diagnosis; 6: The Diagnostic Approach to the Febrile Neutropenic Patient: Clinical Considerations; 6.1 Introduction; 6.2 Neutropenia and Timing of Neutropenic Fevers; 6.3 Risks and Predictors for Neutropenic Fever; 6.4 Classification of Neutropenic Fever Syndromes; 6.5 Is the Patient Febrile? Measurement of Body Temperature |
|
6.6 Risk for Serious Medical Complications Associated with the Neutropenic Fever Syndrome6.7 Presentation to the Outpatient Clinic or to the Emergency Department; References; 7: Diagnostic Radiology in Hematological Patients with Febrile Neutropenia; 7.1 Early Detection of Pneumonia; 7.1.1 Conventional Chest Radiograph; 7.1.2 CT Technique and Terminology; 7.1.3 CT; 7.1.4 Magnetic-Resonance Tomography (MRI); 7.1.5 Recommendation for Clinical Practice; 7.2 Monitoring of Lung Infiltrates; 7.3 Characterization of Pneumonia; 7.3.1 Bacterial Pneumonia; 7.3.2 Fungal Pneumonia |
| Summary |
Infections are among the most frequent complications in patients with hematological malignancies and in those undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation. A profound knowledge on the epidemiology, diagnostic approaches, treatment modalities and prophylactic strategies is essential for the clinical management of these complications in patients who are often severely immunocompromised owing to their underlying diseases and in particular, the intensive myelosuppressive chemo and immunotherapy. This textbook provides a clinically oriented, compact and u |
| Analysis |
chirurgie |
|
surgery |
|
transplantatie |
|
transplantation |
|
geneeskunde |
|
medicine |
|
volksgezondheid |
|
public health |
|
oncologie |
|
oncology |
|
hematologie |
|
haematology |
|
Medicine (General) |
|
Geneeskunde (algemeen) |
| Notes |
Includes index |
| Bibliography |
Includes bibliographical references at the end of each chapters and index |
| Notes |
Online resource; title from PDF title page (SpringerLink, viewed December 22, 2014) |
| Subject |
Bloodborne infections.
|
|
Blood -- Diseases.
|
|
Hematologic Diseases -- complications
|
|
Anti-Bacterial Agents -- therapeutic use
|
|
Hematopoietic Cell Growth Factors -- therapeutic use
|
|
Infections -- drug therapy
|
|
Infection Control
|
|
Hematologic Diseases
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Blood -- Diseases.
|
|
Bloodborne infections.
|
| Genre/Form |
Electronic books
|
| Form |
Electronic book
|
| Author |
Maschmeyer, Georg, editor
|
|
Rolston, Kenneth V. I., editor.
|
| ISBN |
9783662440001 |
|
3662440008 |
|
3662439999 |
|
9783662439999 |
|
